Abstract
The aim of this study was to test the hypothesis that cardiovascular disease occurs to the greatest extent in persons with prediabetes mellitus who are also insulin resistant. In 2003, 664 non-diabetic women (n = 457) and men (n = 207), aged 52 ± 16 and 53 ± 15 years, were surveyed during a programme for cardiovascular disease prevention. Fasting plasma glucose concentrations defined participants as having normal fasting plasma glucose (fasting plasma glucose <5.6 mmol/L) or prediabetes mellitus (fasting plasma glucose ⩾ 5.6 and <7.0 mmol/L). The tertile of prediabetes mellitus subjects with the highest fasting plasma insulin concentration was classified as insulin resistant. Baseline cardiovascular disease risk factors were accentuated in prediabetes mellitus versus normal fasting glucose, particularly in prediabetes mellitus/insulin resistant. In 2012, 86% of the sample were surveyed again, and the crude incidence for cardiovascular disease was higher in subjects with prediabetes mellitus versus normal fasting glucose (13.7 vs 6.0/100 persons/10 years; age- and sex-adjusted hazard ratio = 1.88, p = 0.052). In prediabetes mellitus, the crude incidences were 22.9 versus 9.6/100 persons/10 years in insulin resistant versus non-i...Continue Reading
References
Jul 1, 1985·Diabetologia·D R MatthewsR C Turner
May 1, 1974·Diabetes·J M Olefsky, G M Reaven
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·J YipG M Reaven
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·F S FacchiniG M Reaven
Aug 13, 2003·Current Atherosclerosis Reports·Gerald M Reaven
Sep 28, 2005·Diabetes Care·Francisco J NóvoaArmando Carrillo
Nov 15, 2007·Diabetes Care·Sun H Kim, Gerald M Reaven
Oct 7, 2009·Annals of Internal Medicine·Mark HelfandLinda L Humphrey
Jun 4, 2010·PLoS Medicine·Nadeem SarwarVilmundur Gudnason
Jul 9, 2010·Lancet·UNKNOWN Emerging Risk Factors CollaborationJ Danesh
May 13, 2011·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Martin R SalazarGerald M Reaven
Jun 22, 2012·PloS One·Kristine FærchLeigh Perreault
Feb 20, 2013·Acta Diabetologica·Fahim AbbasiGerald M Reaven
Jul 3, 2013·Metabolism: Clinical and Experimental·Shubha L BhatSun H Kim
Jan 17, 2014·JAMA : the Journal of the American Medical Association·Anna M SteeleAndrew T Hattersley
Nov 2, 2014·Acta Diabetologica·Danit Ariel, Gerald Reaven
Citations
Jul 20, 2016·Acta Diabetologica·Itahisa Marcelino RodríguezAntonio Cabrera de León
Jun 3, 2017·PloS One·Poonam K PannuZahid Ansari
Jul 18, 2017·Obesity·Sandra A TsaiJun Ma
Jan 26, 2017·Current Eye Research·Serpil YazganIrem Isık
Mar 29, 2019·The Cochrane Database of Systematic Reviews·Siew S LimLisa J Moran
Dec 12, 2018·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·May YangSandra A Tsai
Sep 22, 2018·The Journal of Clinical Endocrinology and Metabolism·Ibiye OweiSam Dagogo-Jack
May 20, 2020·BMJ Open Diabetes Research & Care·Cornelia ThenJochen Seissler
Feb 9, 2019·Cardiovascular Diabetology·Damilola D AdingupuAnn-Cathrine Jönsson-Rylander
Apr 13, 2017·Cardiovascular Diabetology·Judith van HaareMarc van Bilsen
Jun 17, 2020·Medicine·Jia YaoQiu Chen
Mar 6, 2019·Cardiovascular Diabetology·Ferdinando Carlo SassoCelestino Sardu
Oct 31, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Benping ZhangLi Liu
Feb 26, 2021·Journal of Cardiovascular Translational Research·Ye-Shi ChenKai Yin